GE Vernova Inc. GEV
824.58 USD -93.62 (-10.20%)
Nov 4, 2026, 1:49 PM EST
806.40 Day range 879.04
547.96 52-week range 1,174.86
- YTD
- +26.17%
- 1 year
- +50.48%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 1,187.07 +44.0% upside
Now 824.58
- Target (low)
- 940.00
- Target (mean)
- 1,187.07
- Target (high)
- 1,400.00
Ratings (0m) 38 32 buy · 6 hold · 0 sell
- Strong buy6
- Buy26
- Hold6
- Sell0
- Strong sell0
Recommendation trend
- This month 38
- 1 month ago 38
- 2 months ago 37
- 3 months ago 37
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 6.91 | 5.10 – 7.85 | 13.39 | -48.4% | 14.01B | +27.9% | 15 |
| Next quarter | 5.01 | 4.48 – 5.33 | 17.44 | -71.3% | 11.29B | +20.9% | 7 |
| Current year | 31.72 | 30.03 – 32.73 | 17.69 | +79.3% | 46.98B | +23.4% | 22 |
| Next year | 25.88 | 20.20 – 31.87 | 31.72 | -18.4% | 53.57B | +14.0% | 25 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 3, 2026 | Argus Research | Maintained | Buy | Buy |
| Nov 2, 2026 | Guggenheim | Maintained | Buy | Buy |
| Oct 30, 2026 | HSBC | Upgrade | Hold | Buy |
| Oct 30, 2026 | GLJ Research | Maintained | Sell | Sell |
| Oct 29, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Oct 29, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 29, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Oct 29, 2026 | TD Cowen | Maintained | Buy | Buy |
| Oct 29, 2026 | Susquehanna | Maintained | Positive | Positive |
| Oct 28, 2026 | Bernstein | Reiterated | Outperform | Outperform |
| Oct 14, 2026 | Susquehanna | Maintained | Positive | Positive |
| Oct 13, 2026 | Guggenheim | Reiterated | Buy | Buy |
| Oct 9, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Sep 15, 2026 | Bernstein | Reiterated | Outperform | Outperform |
| Sep 14, 2026 | GLJ Research | Initiated | — | Sell |
| Jul 27, 2026 | Mizuho | Maintained | Neutral | Neutral |
| Jul 23, 2026 | Bernstein | Maintained | Outperform | Outperform |
| Jul 23, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Jul 23, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jul 23, 2026 | TD Cowen | Maintained | Buy | Buy |
| Jul 23, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 23, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Jul 23, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jun 17, 2026 | Bernstein | Initiated | — | Outperform |
| Jun 11, 2026 | Jefferies | Maintained | Buy | Buy |
| Apr 27, 2026 | BNP Paribas | Downgrade | Outperform | Neutral |
| Apr 24, 2026 | Jefferies | Maintained | Buy | Buy |
| Apr 23, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Apr 23, 2026 | TD Cowen | Maintained | Buy | Buy |
| Apr 23, 2026 | Barclays | Maintained | Overweight | Overweight |
